Showing results (1-10 of 106) with videos related to
Sort By:
Pageof 11
Immunotargets and Therapy|March 25, 2026
The Role of PD-L1 in Lung Cancer: From Biology to Clinical ApplicationHassan Lamghari, Mehdi KarkouriMicrorna (Shariqah, United Arab Emirates)|May 26, 2022
Diagnostic Value of Potential MicroRNAs in CRC: A Meta-AnalysisSofia Fathi, Fadila Guessous, Mehdi KarkouriSurgical Neurology International|April 13, 2016
Paraganglioma of the filum terminale mimicking neurinoma: Case reportSaid Hilmani, Trezor Ngamasata, Mehdi Karkouri, et al.AIDS (London, England)|July 9, 2010
A review of HIV testing and counseling policies and practices in the Eastern Mediterranean RegionJoumana Hermez, Jenny Petrak, Mehdi Karkouri, et al.Annales De Pathologie|November 30, 2018
[Astroblastoma: A rare glial tumor]Meriem Regragui, Mehdi Karkouri, Khadija Ibahioin, et al.Scientific Reports|November 3, 2021
The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosisAmina Ghouzlani, Abdelhakim Lakhdar, Soumaya Rafii, et al.Journal of the Egyptian National Cancer Institute|June 17, 2025
Immunotherapy for triple-negative breast cancer: current trends and future prospectsAmina Essalihi, Oumaima Bouchra, Khadija Khadiri, et al.Frontiers in Oncology|February 19, 2021
The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor PrognosisAmina Ghouzlani, Soumaya Rafii, Mehdi Karkouri, et al.Annales De Pathologie|May 14, 2003
[Myeloid sarcoma of the brain. A case report]Lamia Jabri, Mehdi Karkouri, Soumaya Zamiati, et al.The Breast Journal|December 11, 2023
The Clinicopathological Features and Prognostic Significance of HER2-Low in Early Breast Tumors Patients Prognostic Comparison of HER-Low and HER2-Negative Breast Cancer Stratified by Hormone Receptor StatusSanaa Gamrani, Laila Akhouayri, Sara Boukansa, et al.Pageof 11